Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Tables)

v3.8.0.1
Earnings (Loss) Per Common Share (Tables)
 9 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):
 
 
 
Three Months ended
March 31,
 
Nine Months ended
March 31,
 
 
 
2018
 
2017
 
2018
 
2017
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to iBio, Inc.
 
$
(3,962)
 
$
(3,913)
 
$
(11,687)
 
$
(10,203)
 
Preferred stock dividends
 
 
64
 
 
26
 
 
195
 
 
26
 
Net loss available to iBio, Inc. stockholders
 
$
(4,026)
 
$
(3,939)
 
$
(11,882)
 
$
(10,229)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
115,449
 
 
89,109
 
 
102,473
 
 
89,109
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.03)
 
$
(0.04)
 
$
(0.12)
 
$
(0.11)